Retatrutide peptide UK — Triple Receptor Agonist Research Peptide
R3ta 30 mg is a premium research-grade peptide supplied as a lyophilised solid, engineered for stability and long-term storage. Each batch is HPLC-tested and verified at ≥ 99.1% purity, with a full Certificate of Analysis provided on every order — giving researchers the confidence to work with a compound they can trust.
What is R3ta?
R3ta is a next-generation triple receptor agonist that simultaneously targets GLP-1, GIP, and glucagon receptors. As one of the most talked-about compounds in current metabolic science, it has attracted significant attention from researchers studying energy homeostasis, glucose regulation, lipid metabolism, and body composition at a cellular level with Retatrutide peptide UK.
Its unique tri-agonist mechanism sets it apart from earlier single or dual receptor compounds, making it a highly valuable tool for advanced research protocols.
Product Specifications
- Amount: 30 mg
- Form: Lyophilised Solid
- Purity: ≥ 99.1% (HPLC-Verified)
- Storage: Keep refrigerated, away from light and moisture
- COA: Included with every order
Why Researchers Choose R3ta 30 mg
- Triple receptor activity for broader research scope
- High-purity lyophilised format for superior stability
- Fully verified with third-party HPLC testing
- COA provided for full research transparency
- Bulk discounts available for larger study requirements
Reviews
There are no reviews yet.